CATALYST PHARMACEUTICAL PARTNERS, INC SC13G

Company

CATALYST PHARMACEUTICALS, INC.

Filed

October 31, 2011

Accession Number

0001393825-11-000031

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →